Search results for "QUALITY"

showing 10 items of 8136 documents

Are Repeated Self-Reports of Psychological Variables Feasible for Patients Near the End of Life at a Palliative Care Unit?

2018

Patient-reported outcome (PRO) measurement is crucial to assess the benefit of psychotherapeutic interventions. Is repeated assessment of psychometric self-report data possible, as inpatient palliative care patients suffer from physical and psychological symptoms? What is the self-perceived strain caused by the assessment? Objective The main objective of this study was to investigate the feasibility of a repeated comprehensive psychometric self-assessment of inpatient palliative care patients. Secondary objectives were the PROs of the psychometric assessment.We conducted a prospective cohort study. Patients admitted to our palliative care unit (PCU) were reviewed for eligibility within 72 h…

AdultMalemedicine.medical_specialtyPalliative carePsychometricsUnit (housing)Young Adult03 medical and health sciences0302 clinical medicineQuality of life (healthcare)GermanySurveys and QuestionnairesNumeric Rating ScalemedicineHumans030212 general & internal medicineProspective cohort studyGeneral NursingDepression (differential diagnoses)AgedAged 80 and overPsychotherapeutic interventionsInpatientsbusiness.industryPalliative CareGeneral MedicineMiddle AgedhumanitiesAnesthesiology and Pain MedicinePatient Satisfaction030220 oncology & carcinogenesisQuality of LifePhysical therapyAnxietyFemalemedicine.symptombusinessJournal of Palliative Medicine
researchProduct

Level of agreement between physician and patient assessment of non-medical health factors.

2018

Background GPs need to consider assorted relevant non-medical factors, such as family or work situations or health insurance coverage, to determine appropriate patient care. If GPs' knowledge of these factors varies according to patients' social position, less advantaged patients might receive poorer care, resulting in the perpetuation of social inequalities in health. Objective To assess social disparities in GPs' knowledge of non-medical factors relevant to patient care. Methods Observational survey of GPs who supervise internships in the Paris metropolitan area. Each of the 52 enrolled GPs randomly selected 70 patients from their patient list. Their knowledge of five relevant factors (co…

AdultMalemedicine.medical_specialtyParisAttitude of Health PersonnelMEDLINE03 medical and health sciencesSocial support0302 clinical medicinePhysiciansSurveys and QuestionnairesMedicineSocial positionHumansSocial inequality030212 general & internal medicineAgedPhysician-Patient RelationsHealth economicsInsurance Healthbusiness.industry030503 health policy & servicesMultilevel modelSocial SupportHealth Status DisparitiesMiddle AgedSocioeconomic FactorsFamily medicineNeeds assessmentObservational studyFemalePerception0305 other medical scienceFamily PracticebusinessNeeds AssessmentFamily practice
researchProduct

Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.

2013

Little is known about the relationship between specific subtypes of treatment-associated motor complications and different domains of health-related Quality of Life (QoL) in patients with Parkinson's disease (PD). Larger studies that investigate these aspects within a cross-cultural setting are scarce.To assess QoL and its association with on-off fluctuations, peak-dose dyskinesias, biphasic dyskinesias, and off-dystonias in PD patients from five European countries.Data from 817 PD patients were collected cross-sectionally in France, Germany, Italy, Spain, and the UK. QoL was measured with the generic EuroQoL 5-Dimension questionnaire (EQ-5D) and the disease-specific Parkinson's Disease Que…

AdultMalemedicine.medical_specialtyParkinson's diseaseNeurologyDiseaseAntiparkinson AgentsQuality of life (healthcare)Surveys and QuestionnairesActivities of Daily LivingMedicineHumansIn patientPsychiatryAgedAged 80 and overDyskinesiasbusiness.industryParkinson DiseaseMiddle Agedmedicine.diseaseEuropeNeurologyDyskinesiaQuality of LifeFemaleNeurology (clinical)Geriatrics and Gerontologymedicine.symptombusinessParkinsonismrelated disorders
researchProduct

Development and validation of the mastocytosis quality of life questionnaire: MC-QoL

2016

Background Mastocytosis is a heterogeneous disease characterized by a clonal expansion of mast cells in various organs. The vast majority of patients affected suffer from signs and symptoms caused by mediator release from mast cells. Although the disease burden is high, there is currently no specific instrument to measure health-related quality of life (HRQoL) impairment in patients with mastocytosis. Objective The aim of this study was to develop and validate a disease-specific tool to assess HRQoL impairment in patients with cutaneous and indolent systemic mastocytosis, the Mastocytosis Quality of Life Questionnaire (MC-QoL). Methods Sixty-two potential MC-QoL items were developed in a co…

AdultMalemedicine.medical_specialtyPathologyAdolescentImmunologyDiseaseMediator releaseYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of lifeSurveys and QuestionnairesInternal medicinemedicineHumansImmunology and AllergyIn patientSystemic mastocytosisDisease burdenAgedFace validityAged 80 and overbusiness.industryReproducibility of ResultsMiddle Agedmedicine.diseasehumanitiesCombined approach030228 respiratory systemPopulation SurveillanceQuality of LifeFemaleFactor Analysis StatisticalbusinessMastocytosisAllergy
researchProduct

The need for psychosocial support and its determinants in a sample of patients undergoing radiooncological treatment of cancer

2008

Abstract Objective The primary goal of this study was to examine the need for psychosocial support in a consecutive sample of cancer patients undergoing radiotherapy (RT). Out of an initial sample of 250 patients, 239 patients could be assessed at the beginning of their RT. Two hundred eight patients were reassessed at the end of RT 4–8 weeks later. Methods Measures comprised the Hornheide Screening Instrument, the Multidimensional Fatigue Inventory, the Resilience Scale, and the Short Form 12 as a measure of health-related quality of life (QoL). Medical and radiological data were continuously registered. Results Within the sample, the need for psychosocial support as reflected in the scree…

AdultMalemedicine.medical_specialtyPatient DropoutsPersonality InventoryHealth Statusmedia_common.quotation_subjectMEDLINEPsychological interventionSample (statistics)Social supportQuality of lifeNeoplasmsSurveys and QuestionnairesAdaptation PsychologicalmedicineHumansPsychiatryFatigueAgedmedia_commonAged 80 and overSocial SupportCancerMiddle AgedResilience Psychologicalmedicine.diseasePsychosocial supportPsychiatry and Mental healthClinical PsychologyQuality of LifePhysical therapyFemalePsychological resiliencePsychologyAttitude to HealthJournal of Psychosomatic Research
researchProduct

The percutaneous closure of patent foramen ovale (PFO): Impact on the quality of life

2012

AdultMalemedicine.medical_specialtyPercutaneousForamen Ovale PatentQuality of lifePFOmedicineHumansClosure (psychology)UltrasonographyForamen ovale patentbusiness.industryFollow up studiesMiddle Agedmedicine.diseaseMigraine with auraSurgeryCryptogenic strokeQuality of LifePatent foramen ovaleFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesInternational Journal of Cardiology
researchProduct

Association between xerostomia, oral and general health, and obesity in adults. A cross-sectional pilot study.

2021

Background The objective of this study was to analyse the association between oral and general health variables and obesity indicators with the sensation of dry mouth or xerostomia as evaluated on the Xerostomia Inventory (XI). Material and Methods A total of 354 randomly selected subjects participated in this cross-sectional pilot study and completed an anonymous questionnaire. Anthropometric, clinical, and xerostomic variables were evaluated. Kruskal-Wallis, ANOVA and Bonferroni test were used for multiple comparisons. ROC curves and multinomial logistic regression were used to determine the (OR) risk of xerostomia. Results A total of 30.7 % of respondents reported xerostomia based on XI.…

AdultMalemedicine.medical_specialtyPilot ProjectsLogistic regressionXerostomiaTooth mobilitysymbols.namesakeaccessstomatognathic systemInternal medicineSurveys and QuestionnairesmedicineHumansObesityGeneral DentistryUNESCO:CIENCIAS MÉDICASOral Medicine and Pathologybusiness.industryResearchGold standardAnthropometrymedicine.diseaseDry mouthObesitystomatognathic diseasesBonferroni correctionCross-Sectional StudiesOtorhinolaryngologycovid-19disabilitysymbolsQuality of LifeSurgerydental careFemaleAnalysis of variancemedicine.symptombusinessMedicina oral, patologia oral y cirugia bucal
researchProduct

Socio-economic cost and health-related quality of life of burn victims in Spain

2008

Abstract Objectives The aim of the study was to determine the economic burden (direct and indirect costs) of burn victims and the impact of burn on health-related quality of life in Spain. Methods In 2003, a cross-sectional study was carried out with 898 burned people. Data regarding demographic features, health resource use, informal care, indirect costs and quality of life were prospectively collected through hospital admission databases and questionnaires filled out by burn victims and caregivers. Results The mean annual cost (direct and indirect) per burn patient was US$ 99,773. The most important categories of costs were those of in-patient care and temporary and permanent disability. …

AdultMalemedicine.medical_specialtyPoison controlCritical Care and Intensive Care MedicineOccupational safety and healthIndirect costsQuality of life (healthcare)Cost of IllnessSurveys and QuestionnairesEnvironmental healthHealth caremedicineHumansProspective Studieshealth care economics and organizationsHealth policyCost–utility analysisbusiness.industryPublic healthHealth Care CostsGeneral MedicineSurgeryHospitalizationCross-Sectional StudiesCaregiversSocioeconomic FactorsSpainQuality of LifeEmergency MedicineFemaleSurgeryBurnsbusinessBurns
researchProduct

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial.

2021

Summary Background There is no evidence that phlebotomy alone is sufficient to steadily maintain haematocrit on target level in low-risk patients with polycythaemia vera. This study aimed to compare the efficacy and safety of ropeginterferon alfa-2b on top of the standard phlebotomy regimen with phlebotomy alone. Methods In 2017, we launched the Low-PV study, a multicentre, open-label, two-arm, parallel-group, investigator-initiated, phase 2 randomised trial with a group-sequential adaptive design. The study involved 21 haematological centres across Italy. Participants were recruited in a consecutive order. Participants enrolled in the study were patients, aged 18–60 years, with a diagnosis…

AdultMalemedicine.medical_specialtyPolycythaemiaNeutropeniaAdolescentPolicithemia veraInterferon alpha-2Polymorphism Single Nucleotidelaw.inventionPolyethylene Glycols03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled trialPhlebotomylawBone MarrowInternal medicinemedicineClinical endpointData monitoring committeeHumansPolycythemia Verabusiness.industryStandard treatmentInterferon-alphaHematologyPhlebotomyJanus Kinase 2Middle AgedInterim analysismedicine.diseaseRecombinant ProteinsRegimenTreatment Outcome030220 oncology & carcinogenesisQuality of LifeFemalebusiness030215 immunologyThe Lancet. Haematology
researchProduct

An observational study to evaluate the long-term outcomes of treatment with etanercept in patients with plaque-type psoriasis

2015

Background There is an unmet need for long-term, real-life data on the effect of a drug-free interval between treatment cycles in patients with plaque psoriasis being treated with etanercept, which is licensed for intermittent and continuous treatment. Objective The aim of this study was to determine the average duration of the drug-free interval between etanercept treatment cycles in patients with plaque psoriasis. Methods This was a non-interventional, open-label, multicentre, prospective study in patients for whom the decision had already been made to initiate treatment with etanercept during routine practice in German centres. Clinical outcomes were documented over 36 months with study …

AdultMalemedicine.medical_specialtyPopulationDermatologyEtanerceptEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePsoriasis Area and Severity IndexInternal medicinePsoriasisClinical endpointHumansPsoriasisMedicineAdverse effecteducationBody surface areaeducation.field_of_studybusiness.industryDermatology Life Quality IndexMiddle Agedmedicine.diseaseSurgeryInfectious Diseases030220 oncology & carcinogenesisFemalebusinessImmunosuppressive Agentsmedicine.drugJournal of the European Academy of Dermatology and Venereology
researchProduct